MyFinsight
Home
About
Contact
Back
Income Statement
CNS Pharmaceuticals, Inc. (CNSP)
source: myfinsight.com
Download
Download image
Interest income
$38,609
Net loss
-$2,374,961
Total other income
(expense)
$34,424
Interest expense
$4,185
Loss from operations
-$2,409,385
Total operating
expenses
$2,409,385
General and
administrative
$1,242,340
Research and development
$1,167,045
Back